The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
The role of short-chain fatty acids in microbiota–gut–brain communication
Open accessAbstract
Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota-gut-brain crosstalk. However, the pathways through which SCFAs might influence psychological functioning, including affective and cognitive processes and their neural basis, have not been fully elucidated. Furthermore, research directly exploring the role of SCFAs as potential mediators of the effects of microbiota-targeted interventions on affective and cognitive functioning is sparse, especially in humans. This Review summarizes existing knowledge on the potential of SCFAs to directly or indirectly mediate microbiota-gut-brain interactions. The effects of SCFAs on cellular systems and their interaction with gut-brain signalling pathways including immune, endocrine, neural and humoral routes are described. The effects of microbiota-targeted interventions such as prebiotics, probiotics and diet on psychological functioning and the putative mediating role of SCFA signalling will also be discussed, as well as the relationship between SCFAs and psychobiological processes. Finally, future directions to facilitate direct investigation of the effect of SCFAs on psychological functioning are outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The gut microbiota influences gut barrier and produce neurotransmitters, amino acids and microbial metabolites61.”
From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's (AD) and Parkinson's (PD) diseases and autism spectrum disorder (ASD) (9, 21, 25–27).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“brain to gut signaling can directly affect the microbiota, either via immune system or gut functions such as motility, release of neurotransmitters and intestinal immune tone (12, 17, 21, 31).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the gut microbiota can interact with the CNS via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation (9, 17, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“altered SCFA production has been demonstrated in a variety of neuropathologies (19, 21, 33–35).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these SCFAs regulate the expression levels of tryptophan 5-hydroxylase 1, the enzyme involved in synthesis of serotonin, and tyrosine hydroxylase, which is involved in a rate-limiting step in the biosynthesis of dopamine, noradrenaline and adrenaline; therefore, producing an effect on brain neurochemistry (21, 55, 56, 116, 117).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microbial metabolites such as short chain fatty acids (SCFAs) exert beneficial effects on psychiatric disorders via the microbiota–gut–brain axis through humoral, hormonal, and immune pathways [12].”
From Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SCFAs exert their physiological activities by acting as endogenous ligands for G-protein-coupled receptors (GPCRs), and modulating gene expression by inhibiting histone deacetylases (HDACs).282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“SCFAs can modulate the levels of neurotransmitters and neurotrophic factors and regulate the expression of tryptophan 5-hydroxylase, the enzyme involved in the synthesis of serotonin, and tyrosine hydroxylase, the enzyme involved in the rate-limiting step in dopamine, noradrenaline, and adrenaline synthesis (18, 132, 164, 222).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
The cited source says what the claim attributes to it.
In the citing paper
“Other pathways through which SCFAs can influence gutbrain communication and brain function include immune, endocrine, neuronal, vagal, and other humoral pathways (360).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [360]
The cited source says what the claim attributes to it.
In the citing paper
“growing evidence supports the idea that SCFAs also exert crucial physiological effects on several organs, including the brain (17, 20, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Accumulating evidence suggests that SCFAs that cross into the CNS have neuroactive properties.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“It was described that SCFAs may modulate the levels of neurotransmitters and neurotrophic factors.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
In the citing paper
“SCFAs are endogenous ligands for a subset of GPCRs, including GPR43 and GPR41, which were subsequently renamed as free fatty acid receptor 2 (FFAR2) and FFAR3, respectively.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“Another important GPCR activated by SCFA is GPR109A, also known as hydroxycarboxylic acid receptor 2 (HCAR2), which is activated by butyrate and β-D-hydroxy butyrate.282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“and intracellular SCFAs can influence gene expression via histone deacetylation (HDAC) inhibition (Dalile et al., 2019)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Moreover, SCFAs are endogenous ligands of orphan G protein-coupled receptors (GPCRs)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Altered SCFA production has also been demonstrated in a variety of neuropathologies (42, 116, 127, 130, 132, 292–295).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Self-citationCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Cited by
Sorted by citations
Items 201–300 of 1,008
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Wu, Y., Xu, H., Tu, X., & Gao, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.730809 · Cited by 117
Li, G., Feng, H., Mao, X.-L., Deng, Y., Wang, X.-B., Zhang, Q., Guo, Y., & Xiao, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04306-0 · Cited by 115
Bonomo, R. R., Cook, T. M., Gavini, C. K., White, C. R., Jones, J. R., Bovo, E., Zima, A. V., Brown, I. A., Dugas, L. R., Zakharian, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006065117 · Cited by 114
Javanshir, N., Hosseini, G. N. G., Sadeghi, M., Esmaeili, R., Satarikia, F., Ahmadian, G., & Fard, N. A. (2021) · Biological Procedures Online · doi:10.1186/s12575-021-00160-w · Cited by 114
Kalkan, A. E., BinMowyna, M. N., Raposo, A., Ahmad, M. F., Ahmed, F., Otayf, A. Y., Carrascosa, C., Saraiva, A., & Karav, S. (2025) · Nutrients · doi:10.3390/nu17081305 · Cited by 116
The gut microbiota — brain axis of insects
Liberti, J., & Engel, P. (2020) · Current Opinion in Insect Science · doi:10.1016/j.cois.2020.01.004 · Cited by 113
Borrego-Ruiz, A., & Borrego, J. J. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110861 · Cited by 111
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 112
Shobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 113
The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer
Delzenne, N. M., Bindels, L. B., Neyrinck, A. M., & Walter, J. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01108-z · Cited by 112
Association of the gut microbiota with cognitive function in midlife
Meyer, K., Lulla, A., Debroy, K., Shikany, J. M., Yaffe, K., Meirelles, O., & Launer, L. J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.43941 · Cited by 110
The gut microbiota–brain axis in neurological disorders
You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024) · MedComm · doi:10.1002/mco2.656 · Cited by 113
Dietary Pattern, Gut Microbiota, and Alzheimer’s Disease
Zhang, M., Zhao, D., Zhou, G., & Li, C. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b08309 · Cited by 109
Sun, B., Ma, T., Li, Y., Yang, N., Li, B., Zhou, X., Guo, S., Zhang, S., Kwok, L., Sun, Z., et al. (2022) · mSystems · doi:10.1128/msystems.00100-22 · Cited by 109
Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
Oroojzadeh, P., Bostanabad, S. Y., & Lotfi, H. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02053-3 · Cited by 109
The gut microbiome: linking dietary fiber to inflammatory diseases
Zhang, F., Fan, D., Huang, J., & Zuo, T. (2022) · Medicine in Microecology · doi:10.1016/j.medmic.2022.100070 · Cited by 110
The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian, A., Engen, P. A., Bonvegna, S., & Cilia, R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 108
Ni, Y., Hu, L., Yang, S., Ni, L., Ma, L., Zhao, Y., Zheng, A., Jin, Y., & Fu, Z. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130952 · Cited by 107
Kim, C.-S. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.10.008 · Cited by 107
How Can Insulin Resistance Cause Alzheimer’s Disease?
Yoon, J. H., Hwang, J., Son, S. U., Choi, J., You, S.-W., Park, H., Cha, S.-Y., & Maeng, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043506 · Cited by 106
Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers
Zeng, L., Qian, Y., Cui, X., Zhao, J., Ning, Z., Cha, J., Wang, K., Ge, C., Jia, J., Dou, T., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1675065 · Cited by 102
Forte, N. R., Fernández-Rilo, A. C., Palomba, L., Marzo, V. D., & Cristino, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051554 · Cited by 105
Averina, O. V., Kovtun, A. S., Polyakova, S. I., Savilova, A. M., Rebrikov, D. V., & Даниленко, В. Н. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001178 · Cited by 105
Next-Generation Probiotics for Inflammatory Bowel Disease
Pesce, M., Seguella, L., Re, A., Lu, J., Palenca, I., Corpetti, C., Rurgo, S., Sanseverino, W., Sarnelli, G., & Esposito, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105466 · Cited by 105
Nocerino, R., Filippis, F. D., Cecere, G., Marino, A., Micillo, M., Scala, C. D., Caro, C. D., Calignano, A., Bruno, C., Paparo, L., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15561 · Cited by 104
Zheng, W., Xu, Q., Huang, W., Yan, Q. J., Chen, Y., Zhang, L., Tian, Z., Liu, T., Yuan, X., Liu, C., et al. (2020) · mSystems · doi:10.1128/msystems.00109-20 · Cited by 105
Du, D., Tang, W., Zhou, C., Sun, X., Wei, Z., Zhong, J., & Huang, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5816837 · Cited by 105
Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
Lei, W., Cheng, Y., Gao, J., Liu, X., Shao, L., Kong, Q., Zheng, N., Ling, Z., & Hu, W. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1224155 · Cited by 104
Yang, J., Liang, J., Hu, N., He, N., Liu, B., Liu, G., & Qin, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70091 · Cited by 109
Akkermansia muciniphila: A key player in gut microbiota-based disease modulation
Shaheen, N., Khursheed, W., Gurung, B., & Wang, S. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128317 · Cited by 104
Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
Shukla, P. K., Delotterie, D. F., Xiao, J., Pierre, J. F., Rao, R., McDonald, M. P., & Khan, M. M. (2021) · Cells · doi:10.3390/cells10040779 · Cited by 105
Probiotics for Parkinson's disease: Current evidence and future directions
Tan, A. H., Hor, J. W., Chong, C. W., & Lim, S. (2020) · JGH Open · doi:10.1002/jgh3.12450 · Cited by 103
Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
Kvaková, M., Bertková, I., Štofilová, J., & Savidge, T. (2021) · Foods · doi:10.3390/foods10061297 · Cited by 103
Ischemic stroke and intestinal flora: an insight into brain–gut axis
Hu, W., Kong, X., Wang, H., Li, Y., & Luo, Y. (2022) · European journal of medical research · doi:10.1186/s40001-022-00691-2 · Cited by 102
Interactions between central nervous system and peripheral metabolic organs
Zeng, W., Yang, F., Shen, W. L., Zhan, C., Zheng, P., & Hu, J. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2103-5 · Cited by 103
Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Hou, Y., Li, X., Liu, C., Zhang, M., Zhang, X., Ge, S., & Zhao, L. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111376 · Cited by 101
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Qiao, C.-M., Sun, M., Jia, X.-B., Shi, Y. W., Zhang, B.-P., Zhou, Z.-L., Zhao, L., Cui, C., & Shen, Y. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111772 · Cited by 101
The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids
Sam, Q. H., Ling, H., Yew, W. S., Tan, Z., Ravikumar, S., Chang, M. W., & Chai, L. Y. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126453 · Cited by 101
Li, W., Zhang, L., Xu, Q., Yang, W., Zhao, J., Ren, Y., Yu, Z., & Ma, L. (2022) · Nutrients · doi:10.3390/nu14051069 · Cited by 101
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 100
Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers
Sun, X., Shukla, M., Wang, W., & Li, S. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00610-9 · Cited by 101
Going with the grain: Fiber, cognition, and the microbiota-gut-brain-axis
Berding, K., Carbia, C., & Cryan, J. F. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221995785 · Cited by 100
Citrus flavonoids and the intestinal barrier: Interactions and effects
Wang, M., Zhao, H., Wen, X., Ho, C., & Li, S. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12652 · Cited by 100
Gut-brain axis: Focus on gut metabolites short-chain fatty acids
Guo, C., Huo, Y., Li, Y., Han, Y., & Zhou, D. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i6.1754 · Cited by 100
Wang, M., Veeraperumal, S., Zhong, S., & Cheong, K. (2023) · Foods · doi:10.3390/foods12040878 · Cited by 100
Systematic review of the association between short‐chain fatty acids and allergic diseases
Sasaki, M., Suaini, N. H. A., Afghani, J., Heye, K., O’Mahony, L., Venter, C., Lauener, R. P., Frei, R., & Roduit, C. (2024) · Allergy · doi:10.1111/all.16065 · Cited by 100
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
Liu, Y., Kong, C., Gong, L., Zhang, X., Zhu, Y., Wang, H., Qu, X., Gao, R., Yin, F., Liu, X., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191066 · Cited by 99
Gut-Brain Axis in the Early Postnatal Years of Life: A Developmental Perspective
Jena, A., Montoya, C. A., Mullaney, J. A., Dilger, R. N., Young, W., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00044 · Cited by 98
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Knox, E. G., Aburto, M. R., Tessier, C., Nagpal, J., Clarke, G., O’Driscoll, C. M., & Cryan, J. F. (2022) · iScience · doi:10.1016/j.isci.2022.105648 · Cited by 97
“SCFAs are the main metabolites produced by bacterial fermentation of dietary fiber.(28,29) Butyrate has been identified to protect BBB function(12) and improve BBB integrity in germ free mice treated with either the SCFA or colonized with SCFA producing bacteria.”
Acute Sleep-Wake Cycle Shift Results in Community Alteration of Human Gut Microbiome
Liu, Z., Wei, Z.-Y., Chen, J., Chen, K., Mao, X., Liu, Q., Sun, Y., Zhang, Z., Zhang, Y., Zhou, D., et al. (2020) · mSphere · doi:10.1128/msphere.00914-19 · Cited by 97
Neyrinck, A. M., Rodriguez, J., Zhang, Z., Seethaler, B., Sánchez, C. R., Roumain, M., Hiel, S., Bindels, L. B., Cani, P. D., Paquot, N., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02484-5 · Cited by 97
In Pursuit of Healthy Aging: Effects of Nutrition on Brain Function
Melzer, T. M., Manosso, L. M., Yau, S., Gil‐Mohapel, J., & Brocardo, P. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095026 · Cited by 97
Wang, Z., Liu, J., Li, F., Luo, Y., Ge, P., Zhang, Y., Wen, H., Yang, Q., Ma, S., & Chen, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106321 · Cited by 98
Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy
Chen, K., Yang, M., Yue, N., Zhang, Y., Tian, C., Wei, D., Shi, R., Yao, J., Wang, L., & Li, D. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s470520 · Cited by 97
Cui, Y., Zhu, L., Li, Y., Jiang, S.-L., Sun, Q., Xie, E., Chen, H., Zhao, Z., Qiao, W., Xu, J., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117389 · Cited by 96
Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
Tang, R., & Li, L. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/6632266 · Cited by 96
The Metabolism of Glucosinolates by Gut Microbiota
Sikorska-Zimny, K. M., & Beneduce, L. (2021) · Nutrients · doi:10.3390/nu13082750 · Cited by 96
Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25788 · Cited by 95
RetractedThe old friends hypothesis: evolution, immunoregulation and essential microbial inputs
Rook, G. A. W. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1220481 · Cited by 95
Zhuge, A., Li, S., Han, S., Yuan, Y., Shen, J., Wu, W., Wang, K., Xia, J., Wang, Q., Gu, Y., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.010 · Cited by 97
The Gut–CNS Axis in Multiple Sclerosis
Kadowaki, A., & Quintana, F. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.002 · Cited by 95
Hydroxycinnamic acids on gut microbiota and health
Leonard, W., Zhang, P., Ying, D., & Fang, Z. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12663 · Cited by 94
Woo, V., Eshleman, E. M., Hashimoto‐Hill, S., Whitt, J., Wu, S.-E., Engleman, L., Rice, T., Karns, R. A., Qualls, J. E., Haslam, D. B., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.010 · Cited by 94
Dziedzic, A., Maciak, K., Bliźniewska-Kowalska, K. M., Gałecka, M., Kobierecka, W., & Saluk, J. (2024) · Nutrients · doi:10.3390/nu16071054 · Cited by 94
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 92
Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
Mishima, Y., & Ishihara, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228664 · Cited by 94
Gao, J., Guo, X., Wei, W., Li, R., Hu, K., Liu, X., Jiang, W., Liu, S., Wang, W., Sun, H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0099 · Cited by 93
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?
Schlatterer, K., Peschel, A., & Kretschmer, D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.785833 · Cited by 94
Why Are Bifidobacteria Important for Infants?
Stuivenberg, G. A., Burton, J. P., Bron, P. A., & Reid, G. (2022) · Microorganisms · doi:10.3390/microorganisms10020278 · Cited by 95
The effects of dietary fibers from rice bran and wheat bran on gut microbiota: An overview
Yao, W., Gong, Y., Li, C., Hu, X., & You, L. (2022) · Food Chemistry X · doi:10.1016/j.fochx.2022.100252 · Cited by 93
Moțățăianu, A., Şerban, G. M., & Andone, S. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015094 · Cited by 94
Li, Y., Liu, A., Chen, K., Li, L., Zhang, X., Zou, F., Zhang, X., & Meng, X. (2024) · Environment International · doi:10.1016/j.envint.2024.108479 · Cited by 93
Van-Wehle, T., & Vital, M. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00533-5 · Cited by 93
Lipid metabolism, remodelling and intercellular transfer in the CNS
Vanherle, S., Loix, M., Miron, V. E., Hendriks, J. J. A., & Bogie, J. F. J. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00908-3 · Cited by 96
Donoso, F., Egerton, S., Bastiaanssen, T. F. S., Fitzgerald, P., Gite, S., Fouhy, F., Ross, R. P., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104673 · Cited by 92
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke
Ling, Y., Gong, T., Zhang, J., Gu, Q., Gao, X., Weng, X., Liu, J., & Sun, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.511562 · Cited by 92
Association between premature ovarian insufficiency and gut microbiota
Wu, J., Zhuo, Y., Liu, Y.-L., Chen, Y., Ning, Y., & Yao, J. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03855-w · Cited by 92
Psychobiotics, gut microbiota and fermented foods can help preserving mental health
Casertano, M., Fogliano, V., & Ercolini, D. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110892 · Cited by 92
Yu, Y., Zhang, B., Ji, P., Zuo, Z., Huang, Y., Wang, N., Liu, C., Liu, S., & Zhao, F. (2022) · Nature Communications · doi:10.1038/s41467-022-28746-2 · Cited by 92
Dietary compounds in modulation of gut microbiota-derived metabolites
Feng, W., Liu, J., Cheng, H., Zhang, D., Tan, Y., & Peng, C. Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.939571 · Cited by 92
Caetano, M. A. F., & Castelucci, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.9985 · Cited by 92
Wei, X., Xin, J., Chen, W., Wang, J., Lv, Y., Wei, Y., Li, Z., Ding, Q., Shen, Y., Xu, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114862 · Cited by 93
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 95
Gut Microbiota as an Endocrine Organ: Unveiling Its Role in Human Physiology and Health
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Applied Sciences · doi:10.3390/app14209383 · Cited by 89
Song, L., Sun, Q., Zheng, H., Zhang, Y., Wang, Y., Liu, S., & Duan, L. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200164 · Cited by 91
Cellulolytic bacteria in the large intestine of mammals
Froidurot, A., & Julliand, V. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2031694 · Cited by 92
Brain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
Maiuolo, J., Bulotta, R. M., Ruga, S., Nucera, S., Macrì, R., Scarano, F., Oppedisano, F., Carresi, C., Gliozzi, M., Musolino, V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136971 · Cited by 91
Chenghan, M., Li, W., Zhao, B., He, Y., Li, Q., Zhang, T., Xiaojie, L., Zhang, K., Yingqian, Z., & Zhong, Z. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15299 · Cited by 93
Carotenoids Diet: Digestion, Gut Microbiota Modulation, and Inflammatory Diseases
Rocha, H. R., Coelho, M. C., Gomes, A., & Pintado, M. (2023) · Nutrients · doi:10.3390/nu15102265 · Cited by 90
Zhang, K.-K., Chen, L., Yang, J.-Z., Liu, J., Li, J.-H., Liu, Y., Li, X., Chen, L., Hsu, C., Zeng, J., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.09.010 · Cited by 90
Underwood, M. A., Mukhopadhyay, S., Lakshminrusimha, S., & Bevins, C. L. (2020) · Journal of Perinatology · doi:10.1038/s41372-020-00829-2 · Cited by 89
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
Bistoletti, M., Bosi, A., Banfi, D., Giaroni, C., & Baj, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 91
Obesity and Multiple Sclerosis—A Multifaceted Association
Schreiner, T. G., & Genes, T.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122689 · Cited by 89
Faraji, N., Payami, B., Ebadpour, N., & Gorji, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105990 · Cited by 89
The Promising Role of Probiotics in Managing the Altered Gut in Autism Spectrum Disorders
Abdellatif, B., McVeigh, C., Bendriss, G., & Châari, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114159 · Cited by 88
Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation
Li, C., Liang, Y., & Qiao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.863407 · Cited by 88
Metadata
- Authors
- Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Verbeke, Kristin
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-05-23
- Volume
- 16
- Issue
- 8
- Pages
- 461-478
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2946372752
- Cited by
- 3,357
- References
- 289
- Citations by year
- 2026: 631 · 2025: 685 · 2024: 567 · 2023: 511 · 2022: 429 · 2021: 334 · 2020: 174 · 2019: 25
- FWCI
- 21.30
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, microbiota-gut-brain axis, dietary fiber fermentation, gut microbiota, psychological functioning, emotional processing, cognitive processes, prebiotics, probiotics, microbiota-targeted interventions, immune signaling, hormone signaling, psychobiology
- MeSH terms
- Gastrointestinal Microbiome, Animals, Mental Disorders, Brain, Dietary Fiber, Disease Models, Animal, Fatty Acids, Volatile, Humans, Neural Pathways, Signal Transduction, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
